Please ensure Javascript is enabled for purposes of website accessibility

Why Aurora Cannabis, Canopy, and Sundial Stocks Popped on Friday

By Rich Smith - May 13, 2022 at 1:53PM

Key Points

  • Aurora Cannabis "beat on sales" in its fiscal Q3 earnings report released last night.
  • Aurora's losses during the quarter, on the other hand, were staggeringly large.
  • Can Aurora cut costs fast enough to make up the difference?

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Aurora just "beat" on sales -- but its losses this past quarter were mind-boggling.

What happened

Canadian cannabis company Aurora Cannabis (ACB 2.37%) reported its fiscal third-quarter 2022 earnings last night, and in so doing, sparked a rally across the cannabis sector today. As of 1 p.m. ET, shares of Aurora Cannabis itself are already up 13%, and peer producers Canopy Growth (CGC 1.13%) and Sundial Growers (SNDL -2.86%) are benefiting as well -- up 8.5% and 5.9%, respectively.

But was the news really good enough to justify this rally?

Marijuana plants.

Image source: Getty Images.

So what

Heading into Q3, analysts had forecast that Aurora Cannabis would lose $0.19 per share (0.25 Canadian dollars, and furthermore, this was a pro forma prediction) on sales of $41.5 million -- about CA$53.7 million.  

Aurora actually exceeded analyst predictions on sales. Sales for the quarter declined only 9% to CA$50.4 million, with consumer cannabis sales way down -- off 43% -- but sales of medicinal marijuana up 8%. It was this sales number last night, I suspect, that accounts for investors' enthusiasm about Aurora Cannabis and its peers today.

On the earnings front, however, the news was less good. Aurora lost about CA$1 billion in fiscal Q3 -- which is quite a lot of money for a company valued at less than half a billion U.S. dollars to lose, and works out to roughly CA$4.72 per share according to Aurora's SEC filing. In the earnings release itself, Aurora didn't even bother to calculate per share losses, preferring to give its financial results in the form of adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA), by which metric its losses seemed slimmer -- only CA$12.3 million.    

Now what

So, no. To be frank, despite the relatively good sales news, given how much money Aurora is still losing, I'm not at all convinced that the investors bidding up shares of Canopy or Sundial (or Aurora itself for that matter) on this news are making the right call.

That being said, Aurora did try to parlay its "sales beat" into further momentum for its stock, saying that it is doubling down on cost-cutting and planning to reduce its operating costs by CA$150 million to CA$170 million, annually, by fiscal H1 2023 (or in other words, before the end of this calendar year). Aurora further stated that it expects to achieve "adjusted EBITDA profitability" by the end of this year. Helping with that, Aurora noted that gross margins in the medicinal marijuana business improved during the quarter, even as consumer cannabis profit margins continued to deteriorate.

Can Aurora cut its costs fast enough to make up the difference, and deliver its promised "adjusted EBITDA profitability"? Perhaps, and if it succeeds, that might be enough to keep this rally going for it and its peers. That being said, I have to point out that even CA$170 million in cost-cutting won't make much of a dent in GAAP losses that are running at CA$1 billion. It won't turn "adjusted EBITDA profitability" into anything resembling actual profitability.

And until Aurora -- or any of these cannabis companies for that matter -- proves it can earn an actual profit selling marijuana, I won't be investing my own money in marijuana stocks.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Aurora Cannabis Stock Quote
Aurora Cannabis
$3.02 (2.37%) $0.07
Canopy Growth Stock Quote
Canopy Growth
$5.79 (1.13%) $0.07
Sundial Growers Inc. Stock Quote
Sundial Growers Inc.
$0.45 (-2.86%) $0.01

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/17/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.